Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Clinical trial NCT00711035 · COMPLETED
Trial details
- NCT number
- NCT00711035
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.